Benchmark Reiterates Buy on Harvard Bioscience, Maintains $4 Price Target
Benchmark analyst Kenneth Bruce reiterates Harvard Bioscience (NASDAQ:HBIO) with a Buy and maintains $4 price target.
Benchmark Reiterates Buy on Archer Aviation, Maintains $12 Price Target
Benchmark analyst Josh Sullivan reiterates Archer Aviation (NYSE:ACHR) with a Buy and maintains $12 price target.
Benchmark Reiterates Buy on Getty Images Holdings, Maintains $9 Price Target
Benchmark analyst Mark Zgutowicz reiterates Getty Images Holdings (NYSE:GETY) with a Buy and maintains $9 price target.
Benchmark Reiterates Buy on JD.com, Maintains $76 Price Target
Benchmark analyst Fawne Jiang reiterates JD.com (NASDAQ:JD) with a Buy and maintains $76 price target.
Stephens & Co. Reiterates Equal-Weight on Yellow, Maintains $3 Price Target
Stephens & Co. analyst Jack Atkins reiterates Yellow (NASDAQ:YELL) with a Equal-Weight and maintains $3 price target.
Cantor Fitzgerald Reiterates Overweight on Enovix, Maintains $25 Price Target
Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $25 price target.
RBC Capital Reiterates Sector Perform on Northwest Natural Hldg, Maintains $52 Price Target
RBC Capital analyst Shelby Tucker reiterates Northwest Natural Hldg (NYSE:NWN) with a Sector Perform and maintains $52 price target.
RBC Capital Maintains Outperform on Pliant Therapeutics, Lowers Price Target to $58
RBC Capital analyst Brian Abrahams maintains Pliant Therapeutics (NASDAQ:PLRX) with a Outperform and lowers the price target from $60 to $58.
RBC Capital Maintains Outperform on Granite REIT, Raises Price Target to C$103
RBC Capital analyst Pammi Bir maintains Granite REIT (TSX:GRT) with a Outperform and raises the price target from C$100 to C$103.
Truist Securities Maintains Buy on a.k.a. Brands Holding, Lowers Price Target to $2.6
Truist Securities analyst Youssef Squali maintains a.k.a. Brands Holding (NYSE:AKA) with a Buy and lowers the price target from $4 to $2.6.